Leaflet MYKRONOR 10mcg / ml solution for injection / infusion


Indicated for: shock; acute hypotension

Substance: noradrenaline (vasopressor)

ATC: C01CA03 (Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Adrenergic and dopaminergic agents)

Noradrenaline is a sympathomimetic agent used in the treatment of severe hypotension and septic shock. It works by stimulating alpha and beta adrenergic receptors, increasing vascular tone and blood pressure.

The medication is administered intravenously, as directed by a doctor, usually as a continuous infusion. It is important for administration to be performed under careful monitoring to prevent complications.

Patients should be aware of potential side effects, such as arrhythmias, hypertension, or tissue ischemia. It is important to inform the doctor of any unusual symptoms.

Common side effects include arrhythmias, hypertension, and tissue ischemia. In rare cases, severe reactions such as tissue necrosis at the injection site may occur. Patients should be informed of these risks before use.

General data about MYKRONOR 10mcg / ml

  • Substance: noradrenaline
  • Date of last drug list: 01-03-2024
  • Commercial code: W68373003
  • Concentration: 10mcg / ml
  • Pharmaceutical form: solution for injection / infusion
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: LABORATOIRE AGUETTANT - FRANTA
  • Holder: LABORATOIRE AGUETTANT - FRANTA
  • Number: 14139/2021/03
  • Shelf life: 2 years

Concentrations available for noradrenaline

  • 0.2%
  • 0.25mg/ml
  • 0.5mg/ml
  • 10mcg/ml
  • 1mg/ml
  • 2mg/ml